Capillary Technologies India Ltd
Capillary Technologies India Ltd (CAPILLARY) last reported results for the quarter ended Jun 2026, with sales of ₹257 crore and net profit of ₹-9.55 crore. The stock last traded at ₹569, a market capitalisation of ₹4,530 crore, on a P/E of 88.4. Over the past 52 weeks the stock has ranged between ₹438 and ₹799. Figures are as of 6 Oct 2026 and are not real time.
Capillary Technologies India Ltd share price and key metrics
- Current price
- ₹569
- Market cap
- ₹4,530 cr
- Stock P/E
- 88.4
- Book value
- ₹129
- ROE
- 2.95%
- ROCE
- 3.42%
- Dividend yield
- 0.00%
- 52w high / low
- 799/438
Metrics as of 6 Oct 2026. Not real time.
Track Capillary Technologies India Ltd
Cruxal reads every Capillary Technologies India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Capillary Technologies India Ltd growth and returns
- 10 Years
- %
- 5 Years
- 34%
- 3 Years
- 32%
- TTM
- 23%
- 10 Years
- %
- 5 Years
- 25%
- 3 Years
- 31%
- TTM
- 322%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- -12%
- 3 Years
- -2%
- Last Year
- 3%
Capillary Technologies India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹257 cr, up 42.7% from ₹180 cr a year earlier. Net profit swung to a loss of ₹9.55 cr.
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 159 | 152 | 180 | 179 | 184 | 191 | 257 |
| Expenses | 136 | 125 | 162 | 161 | 159 | 160 | 216 |
| Operating profit | 22.96 | 27.53 | 17.84 | 18.65 | 24.98 | 31.4 | 40.3 |
| OPM % | 14.44% | 18.10% | 9.92% | 10.40% | 13.57% | 16.41% | 15.70% |
| Other income | 0.34 | -0.66 | 1.16 | 2.18 | 3.68 | 31.67 | -27.68 |
| Interest | 1.67 | 1.6 | 1.17 | 1.77 | 1.46 | 1.07 | 1.17 |
| Depreciation | 12.84 | 16.5 | 17.28 | 19.1 | 19.08 | 19.52 | 20.04 |
| Profit before tax | 8.79 | 8.77 | 0.55 | -0.04 | 8.12 | 42.48 | -8.59 |
| Tax % | -16.72% | -12.20% | -34.55% | -800.00% | 1.48% | -2.10% | 11.18% |
| Net profit | 10.26 | 9.84 | 0.75 | 0.29 | 7.99 | 43.36 | -9.55 |
| EPS (₹) | 1.40 | 1.34 | 0.10 | 0.04 | 1.01 | 5.46 | -1.20 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Capillary Technologies India Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 171 | 223 | 323 | 525 | 598 | 735 | 811 |
| Operating profit | -13 | -51 | -64 | -12 | 65 | 93 | 115 |
| OPM % | -7% | -23% | -20% | -2.2% | 11% | 13% | 14% |
| Net profit | -23 | -101 | -88 | -57 | 13 | 52 | 42 |
| EPS (₹) | -97.84 | -20.16 | -16.58 | -7.78 | 1.81 | 6.60 | 5.31 |
TTM is the trailing twelve months to the most recent quarter.
Capillary Technologies India Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 2 | 10 | 11 | 15 | 15 | 16 |
| Reserves | 10 | 106 | 156 | 524 | 554 | 1,008 |
| Borrowings | 20 | 83 | 149 | 77 | 106 | 54 |
| Other liabilities | 108 | 149 | 130 | 254 | 163 | 222 |
| Total liabilities | 140 | 347 | 446 | 870 | 838 | 1,299 |
| Fixed assets | 27 | 215 | 203 | 298 | 301 | 460 |
| CWIP | 0 | 0 | 6 | 3 | -0 | -0 |
| Investments | -0 | -0 | -0 | 70 | -0 | 136 |
| Other assets | 113 | 132 | 237 | 499 | 537 | 702 |
| Total assets | 140 | 347 | 446 | 870 | 838 | 1,299 |
As reported by the company. Total assets equal total liabilities by construction.
Capillary Technologies India Ltd cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 1 | 7 | -20 | 97 | -46 | 150 |
| Cash from investing | -14 | -113 | -100 | -180 | 66 | -590 |
| Cash from financing | 28 | 96 | 137 | 218 | 4 | 270 |
| Net cash flow | 15 | -9 | 17 | 134 | 24 | -169 |
| Free cash flow | -11 | -10 | -48 | 60 | -94 | 111 |
| CFO / operating profit | 67% | -20% | 35% | -827% | -65% | 168% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Capillary Technologies India Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | -68% | -36% | -12% | 2% | 3% |
| Debtor days | 117 | 93 | 91 | 101 | 98 | 90 |
| Cash conversion cycle | 117 | 93 | 91 | 101 | 98 | 90 |
| Working capital days | -106 | -184 | -136 | -66 | -28 | -10 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Capillary Technologies India Ltd shareholding pattern
Promoters held 51.45% at Jun 2026, down from 52.29% at Dec 2025. FIIs 3.34% and DIIs 19.38%.
| % held | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 52.29% | 52.23% | 51.45% |
| FIIs | 3.93% | 3.43% | 3.34% |
| DIIs | 17.75% | 18.60% | 19.38% |
| Public | 26.03% | 25.75% | 25.83% |
| No. of shareholders | 20,521 | 16,620 | 16,688 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Capillary Technologies India Ltd corporate filings
- Company schedules analyst/institutional investor meet, no financial or operational details disclosedCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has announced an upcoming analyst and investor meet…
Read the full analysis - Capillary Technologies India Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has issued an intimation regarding a scheduled meeting…
Read the full analysis - Capillary Technologies India Ltd issues clarification on recent stock price movementCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has issued a formal clarification regarding the recent…
Read the full analysis - Intimation for Trading Window Closure for the quarter ending 30th September, 2026.Insider Trading / SASTlow impact
- Mirae Asset Mutual Fund Divests Stake in Capillary Technologies India Ltd.Insider Trading / SASTlow impact
Cruxal's analysis: Capillary Technologies India Ltd. has reported a regulatory disclosure indicating that…
Read the full analysis - Mirae Asset Mutual Fund reduces stake in Capillary Technologies India Ltd. via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Capillary Technologies India Ltd. has reported a disclosure under SEBI Regulation 29(2)…
Read the full analysis - Mirae Asset Mutual Fund reduces stake in Capillary Technologies India Ltd. by 0.22% via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Mirae Asset Mutual Fund has disclosed a reduction in its shareholding in Capillary…
Read the full analysis - Capillary Technologies India Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has issued an intimation regarding a scheduled meeting…
Read the full analysis - Capillary Technologies Announces Senior Management Appointments and Investor Relations TransitionCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Limited has formally designated seven key executives as…
Read the full analysis - Capillary Technologies India Limited concludes 14th Annual General Meeting with approval of all resolutionsAGM/EGMlow impact
Cruxal's analysis: Capillary Technologies India Limited has successfully concluded its 14th Annual General…
Read the full analysis - Capillary Technologies India Limited concludes 14th AGM; reports FY 2025-26 revenue of 743.6 crore and adjusted EBITDA of 106.9 croreAGM/EGMlow impact
Cruxal's analysis: Capillary Technologies India Limited held its 14th Annual General Meeting on August 28…
Read the full analysis - Capillary Technologies issues clarification regarding promoter entity transactionCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has issued a formal clarification regarding a…
Read the full analysis - Kotak Mahindra Mutual Fund crosses 5% stake threshold in Capillary Technologies India Ltd.Insider Trading / SASTmedium impact
Cruxal's analysis: Capillary Technologies India Ltd. has received a disclosure indicating that Kotak…
Read the full analysis - Capillary Technologies Promoter Divests 4.14% Stake via Block DealInsider Trading / SASTmedium impact
Cruxal's analysis: Capillary Technologies India Limited has disclosed that its promoter, Capillary…
Read the full analysis - Capillary Technologies International Pte. Ltd. Reduces Promoter Stake by 4.14% via Block DealInsider Trading / SASTmedium impact
Cruxal's analysis: Capillary Technologies India Limited has disclosed that its promoter, Capillary…
Read the full analysis - Capillary Technologies Reports Strong Q1 FY27 Growth with 43% YoY Revenue Increase and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Capillary Technologies India Limited reported Q1 FY27 revenue of INR 256 crore, a 43% YoY…
Read the full analysis - Capillary Technologies Reports Weak Q1 FY27 Results with Net Loss of 9.55 croreCompany Updatehigh impact
Cruxal's analysis: Capillary Technologies India Limited reported a challenging quarter for the period ended…
Read the full analysis - Capillary Technologies India Limited discloses audio recording of Q1 FY27 earnings conference callCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Limited has formally filed the audio recording of its Q1…
Read the full analysis - Capillary Technologies submits Q1 2027 Monitoring Agency reportCompany Updatelow impact
Cruxal's analysis: Capillary Technologies India Ltd has announced the submission of its Monitoring Agency…
Read the full analysis - Capillary Technologies Reports Robust Q1 FY27 Operational Growth with 43% Revenue Surge and 132% Adjusted EBITDA Growth, Despite One-Time Cyber Fraud LossCompany Updatehigh impact
Cruxal's analysis: Capillary Technologies India Limited announced strong operational performance for Q1…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.